Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Marketing
Marketing
Neurocrine asks ‘What the C@H?!’ in new hyperplasia campaign
Neurocrine Biosciences’ newest educational campaign wants frustrated congenital adrenal hyperplasia patients to ask, “What the C@H?!”
Andrea Park
Apr 25, 2024 12:04pm
Medtronic backs push to activate heart valve disease patients
Apr 26, 2024 7:35am
Biogen plots 30% Leqembi field force bump, omnichannel campaigns
Apr 25, 2024 6:58am
Roche's juggernaut Vabysmo routs analyst consensus
Apr 24, 2024 11:29am
Biogen's fortunes are trending upward thanks to its new launches
Apr 24, 2024 11:24am
Chiesi survey shows how Fabry drugs are failing patients
Apr 24, 2024 10:25am